|
Volumn 30, Issue 5, 1998, Pages 2407-2410
|
Chronic rejection: Risk factors, regulation, and possible sites of therapeutic intervention
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOPEPTIN;
CYCLOSPORIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW MOLECULAR WEIGHT HEPARIN;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PEPTIDE;
PLATELET DERIVED GROWTH FACTOR;
RAPAMYCIN;
SOMATOMEDIN C;
SOMATOSTATIN;
ARTERIOSCLEROSIS;
CONFERENCE PAPER;
DISEASE PREDISPOSITION;
GENE THERAPY;
GRAFT REJECTION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
REGULATORY MECHANISM;
RISK FACTOR;
VASCULAR SMOOTH MUSCLE;
ANTIBODIES, MONOCLONAL;
ARTERIOSCLEROSIS;
CHRONIC DISEASE;
GENE THERAPY;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
PEPTIDES;
POSTOPERATIVE COMPLICATIONS;
RISK FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0031691039
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00670-8 Document Type: Conference Paper |
Times cited : (19)
|
References (32)
|